(lp0
S'BRIEF-Albany Molecular Research enters into agreement with pharmaceutical ... Reuters - Feb 21, 2017 Albany Molecular Research Inc - entered into an agreement with pharmaceutical group Ferrer and Accord Healthcare, Inc. * Albany Molecular - agreement to develop, manufacture undisclosed complex parenteral drug product for registration, subsequent&nbsp;...'
p1
aS'Albany Molecular Research Inc.  Moves Higher on Volume Spike for March 15 Equities.com - Mar 15, 2017 Albany Molecular Research Inc.  traded on unusually high volume on Mar. 15, as the stock gained 3.32% to close at $13.70.Albany Molecular Research, Inc.  Quarterly EBIT Margin At -10.2535% - Enterprise Leader'
p2
aS'AMRI to Present at Barclays Global Healthcare Conference PR Newswire  - Feb 23, 2017 ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc.  announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 16&nbsp;...'
p3
aS'Albany Molecular Research, Inc.  Valuation By The Numbers Business Review - 13 hours ago The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.'
p4
aS"Moody's affirms Albany Molecular's B3 CFR following announced acquisition of ... Moodys.com   - May 9, 2016 New York, May 09, 2016 -- Moody's Investors Service  today affirmed Albany Molecular Research Inc.'s  ratings, including its B3 Corporate Family Rating , B3-PD Probability of Default Rating  and the B1 rating on the company's&nbsp;..."
p5
aS'Albany Molecular Research Inc.  Plunges 5.35% on March 14 Equities.com - Mar 14, 2017 Albany Molecular Research Inc.  had a rough trading day for Tuesday March 14 as shares tumbled 5.35%, or a loss of $-0.75 per share, to close at $13.26.The Russell Investments Group Ltd. Buys Shares of 217126 Albany Molecular ... - Petro Global News 24'
p6
aS'Albany Molecular Research Inc.  Moves Higher on Volume Spike for March 10 Equities.com - Mar 10, 2017 Albany Molecular Research Inc.  traded on unusually high volume on Mar. 10, as the stock gained 2.63% to close at $13.65.Russell Investments Group Ltd. Buys Shares of 217126 Albany Molecular Research ... - The Cerbat GemHealthcare Oversold Stocks: Genesis Healthcare, Inc. , Albany ... - Benchmark Monitor'
p7
aS'Albany Molecular Research Inc.  Moves Higher on Volume Spike for March 13 Equities.com - Mar 13, 2017 Albany Molecular Research Inc.  traded on unusually high volume on Mar. 13, as the stock gained 2.64% to close at $14.01.Stock Returns: NeoGenomics Inc  is Beating Albany Molecular ... - CML NewsMover inside Traders Limelight: Albany Molecular Research, Inc.  - Is stories'
p8
aS"Albany Molecular Research, Regeneron Pharmaceuticals upbeat Albany Times Union - Aug 4, 2016 Two of the region's biopharmaceutical companies released second-quarter results on Thursday, giving investors and analysts insight into their strengths and goals midway through the fiscal year."
p9
aS'Albany Molecular Research Inc.  Plunges 5.67% on February 22 Equities.com - Feb 22, 2017 Albany Molecular Research Inc.  had a rough trading day for Wednesday February 22 as shares tumbled 5.67%, or a loss of $-0.93 per share, to close at $15.46.Albany Molecular Research, Inc.  Signs Deal With Accord ... - FinancialsTrend'
p10
a.